Cancer prevention has reportedly found a friend in coffee. Specifically, studies point to the reduced risk of developing endometrial cancer for women who are regular coffee drinkers.
Studies have been ongoing to determine the effect of coffee on female health. Among the areas of interest for these studies is the apparent correlation between cancer risk in the female endometrium and coffee-drinking habits.
Huffington Post reports that two major studies compared the data of 456,000 females, 2,800 of whom were found to have developed endometrial cancer. Researchers determined that regular coffee drinkers, who take as many as four cups per day, appear to be at low risk.
Great news for women who LOVE coffee https://t.co/bAuFmLVXqe pic.twitter.com/giqAZOXtvn
— HuffPost Lifestyle (@HPLifestyle) 22 April 2016
WebMD reports that the correlations between coffee intake and endometrial cancer is more of a link rather than cause-and-effect. Melissa Merritt of the Imperial College of London related that her research team analyzed 84 food and their content to determine similar or related association to endometrial cancer risk.
This particular study, which was published in the Cancer Epidemiology, Biomarkers & Prevention journal does not distinguish between decaf and caffeinated coffee. The study is unable to recommend the better selection to aid with lowering endometrial cancer risk.
Determining factors in coffee for reduced endometrial cancer risk are yet being ascertained. However, experts point to the possibility that estrogen decrease because of coffee intake develops a healthier hormone balance in the body. High estrogen levels in females have been found to contribute to endometrial cancer risk, among other factors.
We're a #charity with a difference. We offer #emotional, #practical & #social support to anyone affected by #cancer from our #Oxford Centre. — Maggie's Oxford (@maggiesoxford) April 26, 2016
While cancer is a trying medical condition in general, endometrial cancer deprives a woman of so much. Oxford Mail relates the cancer survivors from Oxfordshire.
Among them is Denise Bright, who lost her ovaries, womb and cervix to endometrial cancer. Should findings such those by Melissa Merritt and her team further develop toward more conclusive evidence, females worldwide would have a better chance at guarding against the risk of cancer.
